French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). | French ...
Boston Pharmaceuticals has linked its metabolic dysfunction-associated steatohepatitis (MASH) prospect to improved outcomes ...
Omega Therapeutics is halting work on its only clinical-stage candidate as part of a strategic refocus centered on three ...
Philips has secured an FDA clearance for what it describes as the world’s first imager to combine spectral CT with ...
Halozyme Therapeutics has bid to buy Evotec for around 2 billion euros ($2.1 billion). Evotec confirmed it received an offer ...
Last month, the NIH announced that it had found evidence of research misconduct by Eliez | This week on "The Top Line," we ...
The two companies have been working together since 2017, and, in 2021, they agreed to collaborate on NM26, a bispecific ...
Two industry veterans are taking the reins at Apriori Bio and Valo Health, biotechs backed by VC firm Flagship Pioneering. Craig Williams has been promoted to CEO-partner at Flagship and is now CEO of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback